These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15272854)

  • 1. Chemical proteomic tool for ligand mapping of CYP antitargets: an NMR-compatible 3D QSAR descriptor in the Heme-Based Coordinate System.
    Yao H; Costache AD; Sem DS
    J Chem Inf Comput Sci; 2004; 44(4):1456-65. PubMed ID: 15272854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteins.
    Kirton SB; Murray CW; Verdonk ML; Taylor RD
    Proteins; 2005 Mar; 58(4):836-44. PubMed ID: 15651036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites.
    Ekins S; de Groot MJ; Jones JP
    Drug Metab Dispos; 2001 Jul; 29(7):936-44. PubMed ID: 11408357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficient in silico screening method based on the protein-compound affinity matrix and its application to the design of a focused library for cytochrome P450 (CYP) ligands.
    Fukunishi Y; Hojo S; Nakamura H
    J Chem Inf Model; 2006; 46(6):2610-22. PubMed ID: 17125201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined 3D QSAR and molecular docking studies to reveal novel cannabinoid ligands with optimum binding activity.
    Durdagi S; Papadopoulos MG; Papahatjis DP; Mavromoustakos T
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6754-63. PubMed ID: 17980589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional quantitative structure-activity relationship analysis of cytochromes p450: effect of incorporating higher-affinity ligands and potential new applications.
    Locuson CW; Wahlstrom JL
    Drug Metab Dispos; 2005 Jul; 33(7):873-8. PubMed ID: 15843486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical proteomics from a nuclear magnetic resonance spectroscopy perspective.
    Sem DS
    Expert Rev Proteomics; 2004 Aug; 1(2):165-78. PubMed ID: 15966811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitemplate alignment method for the development of a reliable 3D-QSAR model for the analysis of MMP3 inhibitors.
    Tuccinardi T; Ortore G; Santos MA; Marques SM; Nuti E; Rossello A; Martinelli A
    J Chem Inf Model; 2009 Jul; 49(7):1715-24. PubMed ID: 19522467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of 3D-QSAR, docking, local-binding energy (LBE) and GRID study of the species differences in the carcinogenicity of benzene derivatives chemicals.
    Fratev F; Benfenati E
    J Mol Graph Model; 2008 Sep; 27(2):147-60. PubMed ID: 18495507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of 3D-QSAR in the rational design of receptor ligands and enzyme inhibitors.
    Mor M; Rivara S; Lodola A; Lorenzi S; Bordi F; Plazzi PV; Spadoni G; Bedini A; Duranti A; Tontini A; Tarzia G
    Chem Biodivers; 2005 Nov; 2(11):1438-51. PubMed ID: 17191945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of drug-like molecular properties: modeling cytochrome p450 interactions.
    Jalaie M; Arimoto R; Gifford E; Schefzick S; Waller CL
    Methods Mol Biol; 2004; 275():449-520. PubMed ID: 15141126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural requirements for factor Xa inhibition by 3-oxybenzamides with neutral P1 substituents: combining X-ray crystallography, 3D-QSAR, and tailored scoring functions.
    Matter H; Will DW; Nazaré M; Schreuder H; Laux V; Wehner V
    J Med Chem; 2005 May; 48(9):3290-312. PubMed ID: 15857135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observation of ligand binding to cytochrome P450 BM-3 by means of solid-state NMR spectroscopy.
    Jovanovic T; McDermott AE
    J Am Chem Soc; 2005 Oct; 127(40):13816-21. PubMed ID: 16201802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecule kernels: a descriptor- and alignment-free quantitative structure-activity relationship approach.
    Mohr JA; Jain BJ; Obermayer K
    J Chem Inf Model; 2008 Sep; 48(9):1868-81. PubMed ID: 18767832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.